NGNE
NeurogeneFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
NGNE vs peer average
15/100
NGNE vs. peer average (F vs. B)
Grade spread
A 3 · B 3 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
ABEO is the first available peer comparator.
Rare-disease gene-therapy biotech with similarly heavy dependence on clinical and regulatory milestones plus financing durability.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NGNE
Neurogene
ABEO
Abeona Therapeutics
Grade
F
A
Momentum
79
14
Value
41
44
Sentiment
24
97
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ABEO
NGNE / ABEO
Grade Position
Below peers
NGNE vs. peer average (F vs. B)
15/100
Momentum
79
NGNEValue
41
ABEOSentiment
24
ABEORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NGNE
ABEO is the first peer returned for this comparison set.